Shanghai Pharmaceuticals Group Co., Ltd. 2025 Semi-annual Equity Distribution Implementation Announcement
Securities code: 601607 Securities abbreviation: Shanghai Pharmaceuticals Announcement number: Lin 2025-118
Shanghai Pharmaceutical Group Co., Ltd.
Announcement on the Implementation of Semi-annual Equity Distribution in 2025
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Distribution ratio per share
Cash dividend per A share is 0.12 yuan
Relevant dates
Class of shares Equity registration date Last trading day Ex-rights (dividend) date Cash dividend payment date
A shares 2025/12/31 - 2026/1/5 2026/1/5 Differentiated dividend transfer: No
1. The session and date of the shareholders’ meeting that approved the distribution plan
This profit distribution plan was reviewed and approved by the company's 2025 second extraordinary general meeting of shareholders on December 9, 2025.
2. Distribution plan
Disbursement year: Half year of 2025
Assign objects:
As of the closing of the Shanghai Stock Exchange in the afternoon of the equity registration date, all A-share shareholders of the company registered with the Shanghai Branch of China Securities Depository and Clearing Corporation (hereinafter referred to as "China Securities Clearing Company Shanghai Branch").
For details on cash dividends to shareholders of H shares, please refer to the relevant announcement dated December 9, 2025 published by the Company on the website of The Stock Exchange of Hong Kong Limited (http://www.hkexnews.hk).
- Distribution plan:
This profit distribution is based on the company's total share capital of 3,708,361,809 shares (including 2,789,289,105 A-share shares) before the implementation of the plan. A cash dividend of 0.12 yuan (tax included) is distributed per share, and a total cash dividend of 445,003,417.08 yuan is distributed, of which A-share cash dividends are 334,714,692.60 yuan.
3. Relevant dates
Class of shares Equity registration date Last trading day Ex-rights (dividend) date Cash dividend payment date
A shares 2025/12/31 - 2026/1/5 2026/1/5
4. Distribution Implementation Methods
- Implementation measures
(1) Dividends for A-shares (including tradable shares with no trading conditions and tradable shares with restricted sales) that are not subject to distribution by the Company are entrusted to the Shanghai Branch of China Securities Settlement Co., Ltd. to be distributed through its fund clearing system to shareholders who are registered after the Shanghai Stock Exchange closes on the equity registration date and have completed designated transactions with each member of the Shanghai Stock Exchange. Investors who have completed designated transactions can receive cash dividends at their designated securities business department on the dividend distribution date. Shareholder dividends that have not completed designated transactions will be temporarily kept by China Securities Clearing Company Shanghai Branch and will be distributed after designated transactions are completed.
(2) If bonus shares are distributed or capitalized, the Shanghai Branch of China Securities Clearing Company shall directly account it into the shareholder's account in proportion based on the number of registered shareholders' shares held after the Shanghai Stock Exchange closes on the equity registration date.
- Issue objects by yourself
The cash dividends for the A shares held by the company's shareholders, Shanghai Pharmaceutical (Group) Co., Ltd., Shanghai Shangshi (Group) Co., Ltd., Shanghai Tandong Enterprise Consulting Services Co., Ltd., and Yunnan Baiyao Group Co., Ltd., will be distributed by the company itself.
Tax deduction instructions
Circulating shares without selling restrictions
(1) For individual shareholders and securities investment funds who hold the company’s A-shares without sales restrictions, according to the Ministry of Finance of the People’s Republic of China, the State Administration of Taxation, and the China Securities Regulatory Commission’s "On Differentiated Personal Income from Dividends and Bonuses of Listed Companies" "Notice on Issues Related to Tax Policies" (Caishui [2015] No. 101), "Notice on Issues Concerning the Implementation of Differentiated Personal Income Tax Policies on Dividends and Bonuses of Listed Companies" (Caishui [2012] No. 85), the shareholding period ( The shareholding period refers to the duration from the date when an individual obtains the company's stocks from the public issuance and transfer market to the day before the date of transfer and delivery of the stocks) within 1 month (including 1 month), the full amount of dividends and dividends shall be included in the taxable income, and the actual tax The negative is 20%; if the shareholding period is more than 1 month to 1 year (including 1 year), the dividend income will be included in the taxable income at 50%, and the actual tax burden is 10%; if the shareholding period exceeds 1 year, the dividend income will be temporarily exempt from personal income tax. When the company implements this profit distribution, no personal income tax will be withheld for the time being. When individual shareholders and securities investment funds transfer their stocks, China Clearing Shanghai Branch will calculate the actual tax payable based on their shareholding period. Securities companies and other share custody institutions will deduct the amount from the personal capital account and transfer it to China Clearing Shanghai Branch. The company entrusts China Clearing Shanghai Branch to pay personal income tax at the corresponding tax rate.
(2) For institutional investors who are resident enterprises under the Enterprise Income Tax Law of the People's Republic of China (hereinafter referred to as the "Enterprise Income Tax Law") and hold the company's A-shares without sales restrictions, the dividend income tax shall be paid by them themselves, and the actual cash dividend distributed is RMB 0.12 per share.
(3) For qualified foreign institutional investors (hereinafter referred to as "QFII") shareholders who hold the company's A shares, the company will follow the State Administration of Taxation's "Notice on Issues Concerning the Withholding and Payment of Corporate Income Tax on Dividends, Dividends and Interests paid by Chinese Resident Enterprises to QFIIs" (State Taxation Letter [2 009] 47), the company withholds and pays corporate income tax at a rate of 10%; if the relevant shareholders believe that the dividend income they receive needs to enjoy the benefits of any tax treaty (arrangement), they can apply to the competent tax authorities on their own after receiving the dividends in accordance with relevant regulations.
If there are other A-share non-resident enterprise shareholders other than the aforementioned QFII (the meaning is the same as in the Enterprise Income Tax Law), they should refer to the relevant provisions of Article 39 of the Enterprise Income Tax Law and pay their own income tax in the place where the income occurs. The actual cash dividend distributed is RMB 0.12 per share.
(4) For investors in the Hong Kong market (including enterprises and individuals) who invest in the company’s A shares through the Shanghai-Hong Kong Stock Connect, their dividends will be distributed in RMB by the company through the Shanghai Branch of China Securities Clearing Co., Ltd. according to the account of the nominal holder of the stock (i.e., Hong Kong Securities Clearing Company Ltd.), with tax deductions in accordance with the "Finance and Finance" According to the relevant provisions of the Notice of the Ministry of Finance, the State Administration of Taxation, and the China Securities Regulatory Commission on Tax Policies for the Pilot Program of the Shanghai-Hong Kong Stock Market Transaction Interconnection Mechanism (Caishui [2014] No. 81), the Company withholds income tax at a rate of 10% and reports the withholding to the competent tax authorities. For Northbound Trading investors who are tax residents of other countries and the tax treaty between their country and China stipulates that the dividend income tax rate is less than 10%, the enterprise or individual may, on its own or through a withholding and payment agent, submit an application to the company's competent tax authority for tax treaty benefits. After review by the competent tax authority, the tax will be refunded based on the difference between the tax paid and the tax payable calculated according to the tax treaty rate. The equity registration date and cash dividend distribution date for Shanghai-Hong Kong Stock Connect investors are consistent with those of the Company's A-share shareholders.
- Circulating shares with sales restrictions
(1) For individual shareholders and securities investment funds holding the company’s restricted A shares, the ban will be lifted in accordance with the relevant provisions of the "Notice on Issues Concerning the Implementation of Differentiated Personal Income Tax Policies on Dividends and Bonuses of Listed Companies" (Caishui [2012] No. 85) Dividends and bonuses obtained later will be taxed in accordance with the relevant provisions of the aforementioned notice, and the shareholding period will be calculated from the date of the lifting of the ban; dividends and dividends obtained before the ban is lifted will be included in the taxable income at a reduced rate of 50%, and a 20% tax rate will be applied to calculate personal income tax, and the actual tax burden will be 10%.
(2) For other institutional investors, their dividend income tax shall be paid by themselves, and the actual cash dividend distributed is RMB 0.12 per share.
5. Consultation methods
Contact Department: Board Office
Contact number: 021-63730908
Contact fax: 021-63289333
Announcement is hereby made.
Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
December 25, 2025